EU Extends Inspection Of Teva-Barr Deal
The European Union's antitrust watchdog pushed back the deadline for its review of Teva Pharmaceutical Industries Ltd.'s proposed multibillion-dollar takeover of generic-drug rival Barr Pharmaceuticals Inc. on Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article